Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung Ouk Nam

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Anticancer Research|June 20, 2013
Tumor-targeted photodynamic therapyNaoto Shirasu, Sung Ouk Nam, Masahide Kuroki
Anticancer Research|May 30, 2012
Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancerKohei Miyata, Fusanori Yotsumoto, Sung Ouk Nam, et al.
Anticancer Research|June 20, 2013
Possible therapeutic targets among the molecules involved in the Warburg effect in tumor cellsSung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Anticancer Research|July 14, 2015
Validity of HB-EGF as Target for Human Neuroblastoma TherapySung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Cancer Medicine|February 4, 2015
Warburg effect regulated by amphiregulin in the development of colorectal cancerSung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Anticancer Research|July 14, 2015
The Safety of Pegylated Liposomal Doxorubicin Plus Irinotecan in Recurrent Ovarian Cancer Patients: A Phase I TrialDaisuke Miyahara, Taeko Ueda, Takahiro Katsuda, et al.
Anticancer Research|July 14, 2015
Clinical Efficacy of Aprepitant in Patients with Gynecological Cancer after Chemotherapy Using Paclitaxel and CarboplatinMiyako Maehara, Taeko Ueda, Daisuke Miyahara, et al.
Anticancer Research|June 30, 2016
Anti-tumor Effect of Intravenous Administration of CRM197 for Triple-negative Breast Cancer TherapySung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Anticancer Research|July 3, 2017
HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of <i>EGFR</i>Fusanori Yotsumoto, Satoshi Fukagawa, Kohei Miyata, et al.
Anticancer Research|July 31, 2014
Pre-clinical study of BK-UM, a novel inhibitor of HB-EGF, for ovarian cancer therapySung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Anticancer Research|June 20, 2013
Tumor-targeted photodynamic therapyNaoto Shirasu, Sung Ouk Nam, Masahide Kuroki
Anticancer Research|May 30, 2012
Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancerKohei Miyata, Fusanori Yotsumoto, Sung Ouk Nam, et al.
Anticancer Research|June 20, 2013
Possible therapeutic targets among the molecules involved in the Warburg effect in tumor cellsSung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Anticancer Research|July 14, 2015
Validity of HB-EGF as Target for Human Neuroblastoma TherapySung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Cancer Medicine|February 4, 2015
Warburg effect regulated by amphiregulin in the development of colorectal cancerSung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Anticancer Research|July 14, 2015
The Safety of Pegylated Liposomal Doxorubicin Plus Irinotecan in Recurrent Ovarian Cancer Patients: A Phase I TrialDaisuke Miyahara, Taeko Ueda, Takahiro Katsuda, et al.
Anticancer Research|July 14, 2015
Clinical Efficacy of Aprepitant in Patients with Gynecological Cancer after Chemotherapy Using Paclitaxel and CarboplatinMiyako Maehara, Taeko Ueda, Daisuke Miyahara, et al.
Anticancer Research|June 30, 2016
Anti-tumor Effect of Intravenous Administration of CRM197 for Triple-negative Breast Cancer TherapySung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Anticancer Research|July 3, 2017
HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of <i>EGFR</i>Fusanori Yotsumoto, Satoshi Fukagawa, Kohei Miyata, et al.
Anticancer Research|July 31, 2014
Pre-clinical study of BK-UM, a novel inhibitor of HB-EGF, for ovarian cancer therapySung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Pageof 2